Project Number 1P01AG078106-01 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Cerebral amyloid angiopathy: Role of ApoE, innate immunity, and meningeal lymphatics Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 11. Vascular Etiology e. Cerebral Amyloid Angiopathy Researcher and Organization Principal Investigator HOLTZMAN, DAVID M Principal Investigator First Name DAVID Principal Investigator Last Name HOLTZMAN Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-19-314: NIA Program Project Applications (P01 Clinical Trial Optional) FY Overall Cost $627,998 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official NEWMAN, ELIZABETH
